Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: COVID-19

St. Jude Children’s Research Hospital ENSEMBLE Trial Volunteers Receiving Placebo Might Access J&J Vaccine First

With the recent Emergency Use Authorization (EUA) of the Johnson & Johnson vaccine, who will first receive the vaccine when […]

St. Jude Children’s Research Hospital ENSEMBLE Trial Volunteers Receiving Placebo Might Access J&J Vaccine First
3 days ago
Share

Broad Institute & UBC Researchers Develop COVID-19 Tracking Tool to Help Identify Mutations by Geography

A research team from the Broad institute, the University of British Columbia and 4Fusion Genomics Corporation have developed an open, free public browser […]

Broad Institute & UBC Researchers Develop COVID-19 Tracking Tool to Help Identify Mutations by Geography
3 days ago
Share

By End of Feb, 7% of Americans have Received Full 2-Dose Vaccination Against COVID-19

By the end of February, 7% of the American population had been fully vaccinated with either one of the two […]

By End of Feb 7% of Americans have Received Full 2-Dose Vaccination Against COVID-19
4 days ago
Share

International Clinical Trial ‘REMAP-CAP’ Includes Ivermectin Among Study Drugs for COVID-19 Treatment

The global clinical trial, (REMAP-CAP (NCT02735707), is supported by multiple international funding organizations, including the Canadian Institutes of Health Research, the […]

International Clinical Trial ‘REMAP-CAP’ Includes Ivermectin Among Study Drugs for COVID-19 Treatment
4 days ago
Share

News Roundup | Johnson & Johnson Single-Dose Vaccine Authorized for Emergency Use

Article 1 Johnson and Johnson Single-Dose Vaccine Authorized for Emergency Use Thanks to the Results of the ENSEMBLE Study: Johnson […]

5 days ago
Share

University of Washington-Led Study Reveals Single SARS-CoV-2 Mutation Triggers COVID-19 Variant Expansion & Greater Public Health Concern

A recent study led by University of Washington and involving other agencies and organizations, from the Antibiotic Resistance Monitoring Analysis […]

University of Washington-Led Study Reveals Single SARS-CoV-2 Mutation Triggers COVID-19 Variant Expansion & Greater Public Health Concern
5 days ago
Share

NIAID to Launch Major Clinical Trial Investigating Severe Allergic Reactions with COVID-19 Vaccines from Moderna & Pfizer/BioNTech

As TrialSite has monitored allergic vaccine reactions associated with mRNA-based COVID-19 vaccines under U.S. Food and Drug Administration (FDA) emergency […]

NIAID to Launch Major Clinical Trial Investigating Severe Allergic Reactions with COVID-19 Vaccines from Moderna & PfizerBioNTech
5 days ago
Share

Johnson and Johnson Single-Dose Vaccine Authorized for Emergency Use Thanks to the Results of the ENSEMBLE Study

Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency […]

Johnson and Johnson Single-Dose Vaccine Authorized for Emergency Use Thanks to the Results of the ENSEMBLE Study
5 days ago
Share

Research Shows MMR Vaccine May Protect Against Severe COVID-19 Outcomes

During the 2020 measles outbreak in February, Dr. Desiree E.S. Larenas Linnemann, MD, FAAAAI, Médica Sur Clinical Foundation, led a […]

Research Shows MMR Vaccine May Protect Against Severe COVID-19 Outcomes
6 days ago
Share

China’s Ad5-nCoV COVID-19 Vaccine Granted Conditional Marketing Authorization

This week, the China National Medical Products Administration (NMPA) granted conditional marketing authorization of Recombinant COVID-19 Vaccine (Adenovirus Type 5 […]

China’s Ad5-nCoV COVID-19 Vaccine Granted Conditional Marketing Authorization
6 days ago
Share

Posts navigation

Older posts
Newer posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.